Pfizer stocks surge after announcing their COVID-19 pill - MARCA.com

There seems to be light at the end of the tunnel with the COVID-19 global pandemic thanks to Pfizer, who announced the creation of a treatment to fight the virus. After the announcemnt of a 90% effective pill against death and hospitalization was announced by the pharmaceutical giant, Pfizer's shares surged 11% on Friday.

The idea of a treatment you can actually take home to fight the virus is arguably one of the best news in the fight against the global pandemic the world has waited for nearly two years.

Pfizer decided to make this news public today after Merck got the greenlight from the British Government to start supplying their own pill against COVID. This treatment is not as effective as the one Pfizer claims to have as trials in a COVID critical British hospital reduced hospitalizations only by half.

However, any treatment that can start rolling out at this stage of the pandemic is welcome. Keep in mind that COVID-19 is by far the deadliest pandemic in modern history with nearly 5 million confirmed defunctions.

When can the FDA approve Pfizer's pill?

During a candid talk with CNBC, Pfizer CEO Albert Bourla offered details about the groundbreaking treatment developed by the pharma giant. He confirmed that the patients who took the placebo were the ones who suffered the biggest adverse effects by a large margin.

When asked when this pill could be approved by the FDA in the United States, Bourla was optimistic by saying he expects it to be approved by Thanksgiving. It's no coincidence that Pfizer's stocks rose to the sky after today's events.

Adblock test (Why?)